Skip to main content
PRVAPrivia Health Group, Inc.Sell6.3·$23.53+2.22%
Open full analysis

Privia Health Group, Inc. (PRVA) Stock Analysis

Momentum Cont setup

SellModerate Confidence

Healthcare · Health Information Services

Sell if holding. Engine safety override at $23.53: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.3/10 and A.R:R 1.6:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality.

Privia Health Group organizes physicians and non-physician clinicians into single-TIN Medical Groups across 24 states and DC, providing technology, revenue cycle management, and value-based care infrastructure to 5,380 implemented providers caring for over 5.8 million patients.... Read more

$23.53+20.2% A.UpsideScore 6.3/10#3 of 12 Health Information Services
QualityF-score7 / 9FCF yield3.81%
Stop $22.31Target $28.28(analyst − 10%)A.R:R 1.6:1
Analyst target$31.42+33.5%19 analysts
$28.28our TP
$23.53price
$31.42mean
$40

Sell if holding. Engine safety override at $23.53: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.3/10 and A.R:R 1.6:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality. Chart setup: Trend continuation, RSI 67, MACD bullish. Score 6.3/10, moderate confidence.

Passes 8/8 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 51d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.

10-K grounded · weekly refresh

About Privia Health Group, Inc.

About Privia Health Group, Inc.

Privia Health Group held 5,380 implemented providers across 24 states and the District of Columbia at December 31, 2025, organizing physicians and non-physician clinicians into single-TIN Medical Groups supported by the Privia Technology Solution. The company's ten ACOs served over 298,000 Medicare beneficiaries through the Medicare Shared Savings Program in the 2025 performance year, building on the $233.1 million in shared savings and 32% year-over-year growth delivered in 2024. Since 2014, the company has delivered more than $1.5 billion in total shared savings across government and commercial programs.

Privia Health earns revenue through four main streams: fee-for-service patient care from Owned and Friendly Medical Groups, per-member-per-month care management fees, value-based care revenue in the form of capitated payments and shared savings bonuses, and supplemental services including concierge medicine, virtual visits, behavioral health management, and direct primary care for self-insured employers. The Privia Technology Solution integrates EMR workflows, population health analytics, revenue cycle management, and patient-access tools designed to reduce the administrative burden on physician practices. Payer contracts span commercial insurance, Medicare Advantage, MSSP, and Medicaid — meaning CMS reimbursement rate decisions directly affect a material portion of revenue. Operations are concentrated in certain U.S. states, and the company operates in 9 states solely through VBC arrangements without a locally owned Medical Group footprint.

Show full overview

The U.S. Supreme Court's June 2024 ruling in Loper Bright Enterprises v. Raimondo shifted greater responsibility for statutory interpretation of federal agency actions to courts — a development Privia Health's 10-K identifies as having significant impacts on 'the heavily-regulated healthcare industry.' For Privia Health, this may weigh on CMS guidance governing MSSP shared savings structures and Medicare Advantage rates, as well as Stark Law exception interpretations that underpin the company's physician compensation and management service agreement structures. The company also acknowledges that certain current arrangements may not qualify for all federal Anti-Kickback Statute safe harbors, creating ongoing compliance exposure.

See also: Healthcare · Health Information Services

From Privia Health Group, Inc.'s most recent 10-K filing, extracted June 11, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-17
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Aug 6, 202651d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Quality below floor (3.5 < 4.0)

Key Metrics

P/E (TTM)135.4
P/E (Fwd)21.0
Mkt Cap$2.9B
EV/EBITDA53.3
Profit Mgn1.0%
ROE3.6%
Rev Growth25.8%
Beta0.87
DividendNone
Rating analysts27

Quality Signals

Piotroski F7/9

Options Flow

P/C0.16bullish
IV66%elevated
Max Pain$30+27.5% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMGeographiccertain U.S. states
    10-K Item 1A: 'The operations of the Company and its Medical Groups are concentrated in certain U.S. states'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Gross Margin
0.0
Operating Margin
0.5
Net Margin
0.5
Roe
1.2
Roa
1.2
Moat
4.9
Current Ratio
5.8
Piotroski F
7.8
Fcf Quality
10.0
Excellent cash conversion: 508% FCF/NINo competitive moatStrong Piotroski F-Score: 7/9

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Support Resistance
1.2
Bollinger
1.5
52w Position
7.8
GatesMomentum 7.7>=5.5A.R:R 1.6 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 51d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARMomentum ContSuitability: Aggressive
RSI
67 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $20.48Resistance $23.95

Price Targets

$22
$28
A.Upside+20.2%
A.R:R1.6:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (3.5 < 4.0)

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-06 (51d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is PRVA stock a buy right now?

Sell if holding. Engine safety override at $23.53: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.3/10 and A.R:R 1.6:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality. Chart setup: Trend continuation, RSI 67, MACD bullish. Prior stop was $22.31. Score 6.3/10, moderate confidence.

What is the PRVA stock price target?

Take-profit target: $28.28 (+20.2% upside). Prior stop was $22.31. Stop-loss: $22.31.

What are the risks of investing in PRVA?

Quality below floor (3.5 < 4.0).

Is PRVA overvalued or undervalued?

Privia Health Group, Inc. trades at a P/E of 135.4 (forward 21.0). TrendMatrix value score: 6.6/10. Verdict: Sell.

What do analysts say about PRVA?

27 analysts cover PRVA with a consensus score of 4.2/5. Average price target: $31.

What does Privia Health Group, Inc. do?Privia Health Group organizes physicians and non-physician clinicians into single-TIN Medical Groups across 24 states...

Privia Health Group organizes physicians and non-physician clinicians into single-TIN Medical Groups across 24 states and DC, providing technology, revenue cycle management, and value-based care infrastructure to 5,380 implemented providers caring for over 5.8 million patients. Revenue comes from fee-for-service care, per-member-per-month management fees, capitated and shared savings payments, and supplemental services.

Related stocks: WAY (Waystar Holding Corp.) · HNGE (Hinge Health, Inc.) · VEEV (Veeva Systems Inc.) · HQY (HealthEquity, Inc.) · TEM (Tempus AI, Inc.)
Home Stocks PRVA

Latest news

Latest News

Benzinga21d ago
Benzinga39d agoAnalyst
Benzinga41d agoEarnings
Benzinga41d ago
Benzinga70d ago